The clock is ticking! The compliance deadline for USP <661.1> and <661.2> is approaching quickly, and every day truly matters. These crucial updates are set to replace the existing USP <661> standard, ushering in a new era of greater rigor in qualifying plastic packaging materials and systems for pharmaceutical products.
What’s Changing and Why It Matters
The revised chapters, 661.1 (Plastic Materials of Construction) and 661.2 (Plastic Packaging Systems for Pharmaceutical Use), introduce a more robust and scientifically driven framework for evaluating plastic components. This means:
- Increased Scrutiny: Manufacturers must demonstrate a deeper understanding of their packaging materials.
- Risk-Based Approach: A more detailed, risk-based analysis will be mandated, requiring comprehensive testing to ensure material safety and suitability.
- Focus on Extractables & Leachables (E&L): Expect a heightened emphasis on identifying and quantifying potential extractables from plastic materials that could leach into drug products.
The Consequences of Non-Compliance
Failure to align with these new requirements by the December 1, 2025, deadline could have significant repercussions for your operations and your patients:
- Regulatory Delays: Non-compliant packaging can lead to stalled product approvals and market entry delays.
- Rejected Batches: Products in unqualified packaging may face rejection, resulting in substantial financial losses and supply chain disruptions.
- Risks to Patient Safety: Most importantly, inadequate packaging qualification poses direct risks to patient safety through potential interactions between the packaging and the drug product.
Partner with Gateway Analytical for Confident Compliance
Navigating these complex regulatory updates doesn’t have to be scary. Gateway Analytical provides the specialized expertise and comprehensive testing support you need to meet USP <661.1> and <661.2> requirements with confidence.
Our team of experts understands the nuances of plastic material characterization and extractables & leachables testing. We can help you:
- Develop a robust compliance strategy tailored to your specific drug products.
- Conduct the necessary analytical testing using advanced methodologies.
- Provide detailed reports and documentation to support your regulatory submissions.
Do not wait until it is too late! Ensure your packaging is fully compliant and ready for December 2025. Proactive compliance not only safeguards patient safety but also secures your regulatory success and market presence.
Get Ahead of the Deadline
Contact us today at in**@***************al.com or call us at (724) 443-1900 to discuss your compliance strategy with our experts. Let’s ensure your drug products are protected and prepared for the future.
